https://www.selleckchem.com/products/am-095.html
Objective The objective of this study was to evaluate the pooled estimate of diabetes prevalence in young (50 years was 13.2%, whereas studies with relatively younger patients (mean age less then 50 years) had a pooled prevalence of 9.0% CONCLUSION The overall prevalence of diabetes in COVID-19 patients was found to be 13.2% with studies including relatively elderly patients showing higher rates of diabetes. The intermingled effects of diabetes with other cardiovascular comorbidities warrant age-specific outcomes data including the impac
Like
Comment
Share
